PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $38,000 | +11.8% | 11,947 | +2.1% | 0.01% | 0.0% |
| Q2 2020 | $34,000 | +3.0% | 11,701 | 0.0% | 0.01% | -15.4% |
| Q1 2020 | $33,000 | -17.5% | 11,701 | -5.5% | 0.01% | 0.0% |
| Q4 2019 | $40,000 | -7.0% | 12,382 | -17.8% | 0.01% | -13.3% |
| Q3 2019 | $43,000 | -4.4% | 15,071 | +4.4% | 0.02% | -31.8% |
| Q2 2019 | $45,000 | -15.1% | 14,439 | +0.8% | 0.02% | -15.4% |
| Q1 2019 | $53,000 | – | 14,330 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |